P113: Promising results with anti-PD-1 therapy in primary refractory Hodgkin lymphoma: a single-centre report

• Caterina Zerbi,
• Tanja Lazic,
• Roberta Sciarra,
• Caterina Cristinelli,
• Alessandro Mazzacane,
• Federico Carpi,
• Virginia Valeria Ferretti,
• Giulia Gambini,
• Maurizio Bonfichi,
• Luca Arcaini,
• Manuel Gotti

Affiliations

Caterina Zerbi

1 Department of Molecular Medicine, University of Pavia, Pavia, Italy

Tanja Lazic

1 Department of Molecular Medicine, University of Pavia, Pavia, Italy

Roberta Sciarra

1 Department of Molecular Medicine, University of Pavia, Pavia, Italy

Caterina Cristinelli

1 Department of Molecular Medicine, University of Pavia, Pavia, Italy

Alessandro Mazzacane

1 Department of Molecular Medicine, University of Pavia, Pavia, Italy

Federico Carpi

1 Department of Molecular Medicine, University of Pavia, Pavia, Italy

Virginia Valeria Ferretti

3 Service of Biometry and Clinical Epidemiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Giulia Gambini

3 Service of Biometry and Clinical Epidemiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Maurizio Bonfichi

2 Department of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Luca Arcaini

1 Department of Molecular Medicine, University of Pavia, Pavia, Italy

Manuel Gotti

2 Department of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy